{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:16:47Z","timestamp":1790691407660,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1038\/s41434-022-00359-w","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T13:02:42Z","timestamp":1659013362000},"page":"297-308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["rAAV-mediated over-expression of acid ceramidase prevents retinopathy in a mouse model of Farber lipogranulomatosis"],"prefix":"10.1038","volume":"30","author":[{"given":"Hanmeng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4877-6241","authenticated-orcid":false,"given":"Murtaza S.","family":"Nagree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8165-8995","authenticated-orcid":false,"given":"Jeffrey A.","family":"Medin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7828-614X","authenticated-orcid":false,"given":"Daniel M.","family":"Lipinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"key":"359_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-018-0845-z","volume":"13","author":"FPS Yu","year":"2018","unstructured":"Yu FPS, Amintas S, Levade T, Medin JA. Acid ceramidase deficiency: Farber disease and SMA-PME. Orphanet J Rare Dis. 2018;13:1\u201319.","journal-title":"Orphanet J Rare Dis"},{"key":"359_CR2","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.178.4065.1100","volume":"178","author":"M Sugita","year":"1972","unstructured":"Sugita M, Dulaney JT, Moser HW. Ceramidase deficiency in Farber\u2019s disease (Lipogranulomatosis). Science. 1972;178:1100\u20132.","journal-title":"Science"},{"key":"359_CR3","doi-asserted-by":"publisher","first-page":"33110","DOI":"10.1074\/jbc.271.51.33110","volume":"271","author":"J Koch","year":"1996","unstructured":"Koch J, G\u00e4rtner S, Li C, Quintern LE, Bernardo K, Levran O. et al. Molecular cloning and characterization of a full-length complementary DNAencoding human acid ceramidase: Identification of the first molecular lesion causing farber disease. J Biol Chem. 1996;271:33110\u20135.","journal-title":"J Biol Chem"},{"key":"359_CR4","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/emmm.201302781","volume":"5","author":"MS Sands","year":"2013","unstructured":"Sands MS. Farber disease: Understanding a fatal childhood disorder and dissecting ceramide biology. EMBO Mol. Med. 2013;5:799\u2013801.","journal-title":"EMBO Mol. Med."},{"key":"359_CR5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/gim.2017.133","volume":"20","author":"M Zielonka","year":"2018","unstructured":"Zielonka M, Garbade SF, K\u00f6lker S, Hoffmann GF, Ries M. A cross-sectional quantitative analysis of the natural history of Farber disease: An ultra-orphan condition with rheumatologic and neurological cardinal disease features. Genet. Med. 2018;20:524\u201330.","journal-title":"Genet. Med."},{"key":"359_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1651-2227.1958.tb07665.x","volume":"47","author":"R Zetterstr\u00f6m","year":"1958","unstructured":"Zetterstr\u00f6m R. Disseminated Lipogranulomatosis (Farber\u2019s Disease). Acta Paediatr. 1958;47:501\u201310.","journal-title":"Acta Paediatr"},{"key":"359_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1440-1827.1979.tb01298.x","volume":"29","author":"T Tanaka","year":"1979","unstructured":"Tanaka T, Takahashi K, Hakozaki H, Kimoto H, Suzuki Y. Farber\u2019s Disease (Disseminated Lipogranulomatosis) - A Pathological, Histochemical and Ultrastructural Study-. Pathol. Int. 1979;29:135\u201355.","journal-title":"Pathol. Int."},{"key":"359_CR8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1001\/archopht.1988.01060140323008","volume":"106","author":"MA Zarbin","year":"1988","unstructured":"Zarbin MA, Green WR, Moser AB, Tiffany C. Increased Levels of Ceramide in the Retina of a Patient With Farber\u2019s Disease. Arch. Ophthalmol. 1988;106:1163\u20131163.","journal-title":"Arch. Ophthalmol."},{"key":"359_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/WNO.0000000000000795","volume":"39","author":"AS Alamri","year":"2019","unstructured":"Alamri AS, Alshowaeir DA, AlFaiz AA, Mousawi AI, Mahmoud FH, Alhashim AA. et al. Optic Nerve Involvement in Farber Lipogranulomatosis: Expanding the Phenotypic Spectrum. J Neuro-Ophthalmol. 2019;39:391\u20133.","journal-title":"J Neuro-Ophthalmol"},{"key":"359_CR10","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/emmm.201202301","volume":"5","author":"AM Alayoubi","year":"2013","unstructured":"Alayoubi AM, Wang JCM, Au BCY, Carpentier S, Garcia V, Dworski S, et al. Systemic ceramide accumulation leads to severe and varied pathological consequences. EMBO Mol Med. 2013;5:827\u201342.","journal-title":"EMBO Mol Med."},{"key":"359_CR11","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.3324\/haematol.2014.108530","volume":"100","author":"S Dworski","year":"2015","unstructured":"Dworski S, Berger A, Furlonger C, Moreau JM, Yoshimitsu M, Trentadue J, et al. Markedly perturbed hematopoiesis in acid ceramidase deficient mice. Haematologica. 2015;100:e162\u2013e165.","journal-title":"Haematologica"},{"key":"359_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ajpath.2018.10.018","volume":"189","author":"FPS Yu","year":"2019","unstructured":"Yu FPS, Sajdak BS, Sikora J, Salmon AE, Nagree MS, Gurka J, et al. Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment. Am J Pathol. 2019;189:320\u201338.","journal-title":"Am J Pathol."},{"key":"359_CR13","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1167\/iovs.04-0920","volume":"46","author":"A Barak","year":"2005","unstructured":"Barak A, Goldkorn T, Morse LS. Laser induces apoptosis and ceramide production in human retinal pigment epithelial cells. Investig Ophthalmol Vis Sci. 2005;46:2587\u201391.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"359_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S1388-1981(02)00331-1","volume":"1585","author":"BJ Pettus","year":"2002","unstructured":"Pettus BJ, Chalfant CE, Hannun YA. Ceramide in apoptosis: An overview and current perspectives. Biochim et Biophys Acta Mol Cell Biol Lipids. 2002;1585:114\u201325.","journal-title":"Biochim et Biophys Acta Mol Cell Biol Lipids"},{"key":"359_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00417-008-0957-6","volume":"247","author":"ML Ranty","year":"2009","unstructured":"Ranty ML, Carpentier S, Cournot M, Rico-Lattes I, Malecaze F, Levade T, et al. Ceramide production associated with retinal apoptosis after retinal detachment. Graefe\u2019s Arch Clin Exp Ophthalmol. 2009;247:215\u201324.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol."},{"key":"359_CR16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2174\/1566524018666180322161252","volume":"17","author":"H Lou","year":"2018","unstructured":"Lou H, Kang D, Yang Q, Lian C, Zhang C, Li Z, et al. Erythropoietin Protects Retina Against Ceramide 2-Induced Damage in Rat. Curr Mol Med. 2018;17:699\u2013706.","journal-title":"Curr Mol Med."},{"key":"359_CR17","doi-asserted-by":"publisher","first-page":"18706","DOI":"10.1073\/pnas.1007644107","volume":"107","author":"E Strettoi","year":"2010","unstructured":"Strettoi E, Gargini C, Sala G, Piano I, Gasco P, Ghidoni R. Inhibition of ceramide biosynthesis preserves photoreceptor structure and function in a mouse model of retinitis pigmentosa. Proc Natl Acad Sci USA 2010;107:18706\u201311.","journal-title":"Proc Natl Acad Sci USA"},{"key":"359_CR18","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fncel.2019.00246","volume":"13","author":"MV Sim\u00f3n","year":"2019","unstructured":"Sim\u00f3n MV, Spalm Prado, Vera FH, Rotstein MS. N. P. Sphingolipids as emerging mediators in retina degeneration. Front Cell Neurosci. 2019;13:246.","journal-title":"Front Cell Neurosci"},{"key":"359_CR19","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.survophthal.2006.05.001","volume":"51","author":"S Haddad","year":"2006","unstructured":"Haddad S, Chen CA, Santangelo SL, Seddon JM. The Genetics of Age-Related Macular Degeneration: A Review of Progress to Date. Surv Ophthalmol. 2006;51:316\u201363.","journal-title":"Surv Ophthalmol."},{"key":"359_CR20","doi-asserted-by":"crossref","unstructured":"He X, Schuchman EH. Ceramide and Ischemia\/Reperfusion Injury. J Lipids 2018;2018:1\u201311.","DOI":"10.1155\/2018\/3646725"},{"key":"359_CR21","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/j.1471-4159.2006.03977.x","volume":"98","author":"N Sanvicens","year":"2006","unstructured":"Sanvicens N, Cotter TG. Ceramide is the key mediator of oxidative stress-induced apoptosis in retinal photoreceptor cells. J Neurochem. 2006;98:1432\u201344.","journal-title":"J Neurochem."},{"key":"359_CR22","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1194\/jlr.M082198","volume":"60","author":"E Sugano","year":"2019","unstructured":"Sugano E, Edwards G, Saha S, Wilmott LA, Grambergs RC, Mondal K, et al. Overexpression of acid ceramidase (ASAH1) protects retinal cells (ARPE19) from oxidative stress. J Lipid Res. 2019;60:30\u201343.","journal-title":"J Lipid Res"},{"key":"359_CR23","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1167\/iovs.09-4731","volume":"51","author":"M Opreanu","year":"2010","unstructured":"Opreanu M, Lydic TA, Reid GE, McSorley KM, Esselman WJ, Busik JV. Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid. Investig Ophthalmo Vis Sci. 2010;51:3253\u201363.","journal-title":"Investig Ophthalmo Vis Sci"},{"key":"359_CR24","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1126\/science.1080549","volume":"299","author":"U Acharya","year":"2003","unstructured":"Acharya U, Patel S, Koundakjian E, Nagashima K, Han X, Acharya JK. Modulating sphingolipid biosynthetic pathway rescues photoreceptor degeneration. Science. 2003;299:1740\u20133.","journal-title":"Science."},{"key":"359_CR25","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1167\/iovs.16-19717","volume":"57","author":"J Fan","year":"2016","unstructured":"Fan J, Wu BX, Crosson CE. Suppression of acid sphingomyelinase protects the retina from ischemic injury. Investig Ophthalmol Vis Sci. 2016;57:4476\u201384.","journal-title":"Investig Ophthalmol Vis Sci."},{"key":"359_CR26","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1194\/jlr.M063719","volume":"57","author":"M Stiles","year":"2016","unstructured":"Stiles M, Qi H, Sun E, Tan J, Porter H, Allegood J, et al. Sphingolipid profile alters in retinal dystrophic P23H-1 rats and systemic FTY720 can delay retinal degeneration. J Lipid Res. 2016;57:818\u201331.","journal-title":"J Lipid Res"},{"key":"359_CR27","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/archopht.119.9.1354","volume":"119","author":"R Klein","year":"2001","unstructured":"Klein R, Klein BEK, Jensen SC, Cruickshanks KJ, Lee KE, Danforth L, et al. Medication use and the 5-year incidence of early age-related maculopathy: The Beaver Dam eye study. Arch Ophthalmol. 2001;119:1354\u20139.","journal-title":"Arch Ophthalmol."},{"key":"359_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbacli.2017.02.001","volume":"7","author":"X He","year":"2017","unstructured":"He X, Dworski S, Zhu C, DeAngelis V, Solyom A, Medin JA, et al. Enzyme replacement therapy for Farber disease: Proof-of-concept studies in cells and mice. BBA Clin. 2017;7:85\u201396.","journal-title":"BBA Clin"},{"key":"359_CR29","doi-asserted-by":"publisher","first-page":"e0230898","DOI":"10.1371\/journal.pone.0230898","volume":"15","author":"SF Garbade","year":"2020","unstructured":"Garbade SF, Zielonka M, Mechler K, K\u00f6lker S, Hoffmann GF, Staufner C, et al. FDA orphan drug designations for lysosomal storage disorders - A cross-sectional analysis. PLoS One. 2020;15:e0230898.","journal-title":"PLoS One"},{"key":"359_CR30","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/MOP.0b013e32834c20d9","volume":"23","author":"RH Lachmann","year":"2011","unstructured":"Lachmann RH. Enzyme replacement therapy for lysosomal storage diseases. Curr Opin Pediatr. 2011;23:588\u201393.","journal-title":"Curr Opin Pediatr"},{"key":"359_CR31","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.molmed.2003.08.004","volume":"9","author":"DA Brooks","year":"2003","unstructured":"Brooks DA, Kakavanos R, Hopwood JJ. Significance of immune response to enzyme-replacement therapy for patients with a lysosomal storage disorder. Trend Mol Med. 2003;9:450\u20133.","journal-title":"Trend Mol Med"},{"key":"359_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13052-018-0562-1","volume":"44","author":"D Concolino","year":"2018","unstructured":"Concolino D, Deodato F, Parini R. Enzyme replacement therapy: Efficacy and limitations. Ital J Pediatr. 2018;44:117\u201326.","journal-title":"Ital J Pediatr."},{"key":"359_CR33","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5301\/EJO.2010.6049","volume":"21","author":"J Cunha-Vaz","year":"2011","unstructured":"Cunha-Vaz J, Bernardes R, Lobo C. Blood-retinal barrier. Eur J Ophthalmol. 2011;21:3\u20139.","journal-title":"Eur J Ophthalmol."},{"key":"359_CR34","first-page":"157","volume":"8","author":"DPW Rastall","year":"2015","unstructured":"Rastall DPW, Amalfitano A. Recent advances in gene therapy for lysosomal storage disorders. Appl Clin Genet. 2015;8:157\u201369.","journal-title":"Appl Clin Genet."},{"key":"359_CR35","doi-asserted-by":"publisher","first-page":"52","DOI":"10.2144\/00291bm09","volume":"29","author":"GE Truett","year":"2000","unstructured":"Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML. Preparation of PCR-quality mouse genomic dna with hot sodium hydroxide and tris (HotSHOT). Biotechniques. 2000;29:52\u201354.","journal-title":"Biotechniques"},{"key":"359_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/978-1-4939-7522-8_2","volume":"1715","author":"CA Reid","year":"2018","unstructured":"Reid CA, Lipinski DM. Small and micro-scale recombinant adeno-associated virus production and purification for ocular gene therapy applications. Ret Gene Ther. 2018;1715:19\u201331.","journal-title":"Ret Gene Ther"},{"key":"359_CR37","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1038\/mt.2008.171","volume":"16","author":"DM McCarty","year":"2008","unstructured":"McCarty DM. Self-complementary AAV vectors; advances and applications. Mol Ther. 2008;16:1648\u201356.","journal-title":"Mol Ther"},{"key":"359_CR38","doi-asserted-by":"publisher","first-page":"20097","DOI":"10.1073\/pnas.1912108116","volume":"116","author":"Y Li","year":"2019","unstructured":"Li Y, Benitez BA, Nagree MS, Dearborn JT, Jiang X, Guzman MA, et al. Genetic ablation of acid ceramidase in Krabbe disease confirms the psychosine hypothesis and identifies a new therapeutic target. Proc Natl Acad Sci USA 2019;116:20097\u2013103.","journal-title":"Proc Natl Acad Sci USA"},{"key":"359_CR39","doi-asserted-by":"publisher","first-page":"6429","DOI":"10.1167\/iovs.17-22281","volume":"58","author":"CA Reid","year":"2017","unstructured":"Reid CA, Ertel KJ, Lipinski DM. Improvement of Photoreceptor Targeting via Intravitreal Delivery in Mouse and Human Retina Using Combinatory rAAV2 Capsid Mutant Vectors. Investg Ophthalmol Vis Sci. 2017;58:6429\u201339.","journal-title":"Investg Ophthalmol Vis Sci."},{"key":"359_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/hgtb.2014.120","volume":"26","author":"J Piedra","year":"2015","unstructured":"Piedra J, Ontiveros M, Miravet S, Penalva C, Monfar M, Chillon M. Development of a rapid, robust, and universal PicoGreen-based method to titer adeno-associated vectors. Hum Gene Ther Methods. 2015;26:35\u201342.","journal-title":"Hum Gene Ther Methods"},{"key":"359_CR41","first-page":"6","volume":"61","author":"H Zhang","year":"2020","unstructured":"Zhang H, Sajdak BS, Merriman DK, McCall MA, Carroll J, Lipinski. Daniel M. Electroretinogram of the cone-dominant thirteen-lined ground squirrel during Euthermia and Hibernation in comparison with the rod-dominant Brown Norway rat. Investig Ophthalmol Vis Sci. 2020;61:6\u20136.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"359_CR42","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1080\/01926230290105721","volume":"30","author":"JR Latendresse","year":"2002","unstructured":"Latendresse JR, Warbrittion AR, Jonassen H, Creasy DM. Fixation of testes and eyes using a modified Davidson\u2019s fluid: Comparison with Bouin\u2019s fluid and conventional Davidson\u2019s fluid. Toxicol Pathol. 2002;30:524\u201333.","journal-title":"Toxicol Pathol."},{"key":"359_CR43","doi-asserted-by":"crossref","unstructured":"Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harb Protoc. 2008;5:pdb\u2013prot4986.","DOI":"10.1101\/pdb.prot4986"},{"key":"359_CR44","first-page":"241","volume":"31","author":"M Wolman","year":"1956","unstructured":"Wolman M. The lipids stained by the periodic acid-schiff technic. Biotech Histochem. 1956;31:241\u20135.","journal-title":"Biotech Histochem"},{"key":"359_CR45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/378413a0","volume":"378","author":"JA Brannigan","year":"1995","unstructured":"Brannigan JA, Dodson G, Duggleby HJ, Moody PCE, Smith JL, Tomchick DR, et al. A protein catalytic framework with an N-terminal nucleophile is capable of self-activation. Nature. 1995;378:413\u20136.","journal-title":"Nature."},{"key":"359_CR46","doi-asserted-by":"publisher","first-page":"11253","DOI":"10.1074\/jbc.M709166200","volume":"283","author":"N Shtraizent","year":"2008","unstructured":"Shtraizent N, Eliyahu E, Park JH, He X, Shalgi R, Schuchman EH. Autoproteolytic cleavage and activation of human acid ceramidase. J Biol Chem. 2008;283:11253\u20139.","journal-title":"J Biol Chem"},{"key":"359_CR47","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4103\/1947-2714.179132","volume":"8","author":"AM Abreu Velez","year":"2016","unstructured":"Abreu Velez AM, Upegui Zapata YA, Howard MS. Periodic acid-schiff staining parallels the immunoreactivity seen by direct immunofluorescence in autoimmune skin diseases. N. Am J Med Sci. 2016;8:151\u20135.","journal-title":"N. Am J Med Sci."},{"key":"359_CR48","doi-asserted-by":"publisher","first-page":"1R","DOI":"10.1093\/glycob\/cwi041","volume":"15","author":"B Winchester","year":"2005","unstructured":"Winchester B. Lysosomal metabolism of glycoproteins. Glycobiology. 2005;15:1R\u201315R.","journal-title":"Glycobiology"},{"key":"359_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbacli.2016.02.001","volume":"5","author":"MM Adeva-Andany","year":"2016","unstructured":"Adeva-Andany MM, Gonz\u00e1lez-Luc\u00e1n M, Donapetry-Garc\u00eda C, Fern\u00e1ndez-Fern\u00e1ndez C, Ameneiros-Rodr\u00edguez E. Glycogen metabolism in humans. BBA Clin. 2016;5:85\u2013100.","journal-title":"BBA Clin"},{"key":"359_CR50","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/0962-8924(96)80999-8","volume":"6","author":"K Sandhoff","year":"1996","unstructured":"Sandhoff K, Kolter T. Topology of glycosphingolipid degradation. Trends Cell Biol. 1996;6:98\u2013103.","journal-title":"Trends Cell Biol"},{"key":"359_CR51","doi-asserted-by":"publisher","first-page":"20313","DOI":"10.1074\/jbc.274.29.20313","volume":"274","author":"CE Chalfant","year":"1999","unstructured":"Chalfant CE, Kishikawal K, Mumby MC, Kamibayashi C, Bielawska A, Hannun YA. Long chain ceramides activate protein phosphatase-1 and protein phosphatase-2A. Activation is stereospecific and regulated by phosphatidic acid. J Biol Chem. 1999;274:20313\u20137.","journal-title":"J Biol Chem"},{"key":"359_CR52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/emmm.201201283","volume":"5","author":"SA Saddoughi","year":"2013","unstructured":"Saddoughi SA, Gencer S, Peterson YK, Ward KE, Mukhopadhyay A, Oaks J, et al. Sphingosine analogue drug FTY720 targets I2PP2A\/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol Med. 2013;5:105\u201321.","journal-title":"EMBO Mol Med."},{"key":"359_CR53","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/BF01805484","volume":"8","author":"HC Walvoort","year":"1985","unstructured":"Walvoort HC, Dormans JAMA, van den Ingh TSGAM. Comparative pathology of the canine model of glycogen storage disease type II (Pompe\u2019s disease). J Inherit Metab Dis. 1985;8:38\u201346.","journal-title":"J Inherit Metab Dis"},{"key":"359_CR54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/8904_2015_426","volume":"23","author":"LDM Pena","year":"2015","unstructured":"Pena LDM, Proia AD, Kishnani PS. Postmortem findings and clinical correlates in individuals with infantile-Onset pompe disease. JIMD Rep. 2015;23:45\u201354.","journal-title":"JIMD Rep"},{"key":"359_CR55","doi-asserted-by":"crossref","unstructured":"Solovyeva VV, Shaimardanova AA, Chulpanova DS, Kitaeva KV, Chakrabarti L, Rizvanov, AA. New approaches to Tay-Sachs disease therapy. Front Physiol. 2018;9:1663.","DOI":"10.3389\/fphys.2018.01663"},{"key":"359_CR56","first-page":"72","volume":"12","author":"HN Baris","year":"2014","unstructured":"Baris HN, Cohen IJ, Mistry PK. Gaucher disease: The metabolic defect, pathophysiology, phenotypes and natural history. Pediatr Endocrinol Rev. 2014;12:72\u201381.","journal-title":"Pediatr Endocrinol Rev."},{"key":"359_CR57","first-page":"19","volume":"90","author":"MJ Allen","year":"1997","unstructured":"Allen MJ, Myer BJ, Khokher AM, Rushton N, Cox TM. Pro-inflammatory cytokines and the pathogenesis of Gaucher\u2019s disease: Increased release of interleukin-6 and interleukin-10. QJM Mon J Assoc Phys. 1997;90:19\u201325.","journal-title":"QJM Mon J Assoc Phys"},{"key":"359_CR58","first-page":"205","volume":"10","author":"V Barak","year":"1999","unstructured":"Barak V, Acker M, Nisman B, Kalickman I, Abrahamov A, Zimran A, et al. Cytokines in Gaucher\u2019s disease. Eur Cytokine Netw. 1999;10:205\u201310.","journal-title":"Eur Cytokine Netw."},{"key":"359_CR59","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3389\/fnins.2017.00318","volume":"11","author":"FD Echevarria","year":"2017","unstructured":"Echevarria FD, Formichella CR, Sappington RM. Interleukin-6 deficiency attenuates retinal ganglion cell axonopathy and glaucoma-related vision loss. Front Neurosci. 2017;11:318.","journal-title":"Front Neurosci."},{"key":"359_CR60","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3389\/fimmu.2019.01618","volume":"10","author":"Y Wooff","year":"2019","unstructured":"Wooff Y, Man SM, Aggio-Bruce R, Natoli R, Fernando N. IL-1 family members mediate cell death, inflammation and angiogenesis in retinal degenerative diseases. Front Immunol. 2019;10:1618.","journal-title":"Front Immunol"},{"key":"359_CR61","doi-asserted-by":"publisher","first-page":"29948","DOI":"10.1074\/jbc.M303310200","volume":"278","author":"N Okino","year":"2003","unstructured":"Okino N, He X, Gatt S, Sandhoff K, Ito M, Schuchman EH. The reverse activity of human acid ceramidase. J Biol Chem. 2003;278:29948\u201353.","journal-title":"J Biol Chem"},{"key":"359_CR62","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ajpath.2016.12.005","volume":"187","author":"J Sikora","year":"2017","unstructured":"Sikora J, Dworski S, Jones EE, Kamani MA, Micsenyi MC, Sawada T, et al. Acid Ceramidase Deficiency in Mice Results in a Broad Range of Central Nervous System Abnormalities. Am J Pathol. 2017;187:864\u201383.","journal-title":"Am J Pathol."},{"key":"359_CR63","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1194\/jlr.D600043-JLR200","volume":"48","author":"K Krishnamurthy","year":"2007","unstructured":"Krishnamurthy K, Dasgupta S, Bieberich E. Development and characterization of a novel anti-ceramide antibody. J. Lipid Res. 2007;48:968\u201375.","journal-title":"J. Lipid Res."},{"key":"359_CR64","unstructured":"Asanad S, Karanjia R. Full-Field Electroretinogram. Electrophysiology of Vision. 2022;4:1\u201364."},{"key":"359_CR65","first-page":"18","volume":"32","author":"C Alm\u00e1rcegui","year":"2001","unstructured":"Alm\u00e1rcegui C. Pattern electroretinogram in anterior ischemic optic neuropathy. Rev Neurol. 2001;32:18\u201321.","journal-title":"Rev Neurol."},{"key":"359_CR66","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/0168-5597(94)90131-7","volume":"92","author":"J Froehlich","year":"1994","unstructured":"Froehlich J, Kaufman DI. Use of pattern electroretinography to differentiate acute optic neuritis from acute anterior ischemic optic neuropathy. Electroencephalogr Clin Neurophysiol Evoked Potentials. 1994;92:480\u20136.","journal-title":"Electroencephalogr Clin Neurophysiol Evoked Potentials"},{"key":"359_CR67","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1167\/iovs.05-0875","volume":"47","author":"M Bach","year":"2006","unstructured":"Bach M, Unsoeld AS, Philippin H, Staubach F, Maier P, Walter HS, et al. Pattern ERG as an early glaucoma indicator in ocular hypertension: A long-term, prospective study. Investig Ophthalmol Vis Sci. 2006;47:4881\u20137.","journal-title":"Investig Ophthalmol Vis Sci."},{"key":"359_CR68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S2352-4642(17)30087-1","volume":"2","author":"R Giugliani","year":"2018","unstructured":"Giugliani R, Vairo F, Kubaski F, Poswar F, Riegel M, Baldo G, et al. J. A. Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS. Lancet Child Adolescent Health. 2018;2:56\u201368.","journal-title":"Lancet Child Adolescent Health"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00359-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00359-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00359-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T04:05:06Z","timestamp":1681877106000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-022-00359-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":68,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["359"],"URL":"https:\/\/doi.org\/10.1038\/s41434-022-00359-w","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]},"assertion":[{"value":"14 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}